Aims of the study: Minimally invasive therapy for erectile dysfunction (ED) has changed the frequency of penile prosthesis surgery. The purpose of this study is to describe the changes in frequency, hospital stay, hospital charges and penile prosthesis type in North Carolina. Materials and Methods: The data source was a statewide hospital discharge database which includes data on hospitalized patients for all 151 hospitals in North Carolina. Results: From 1988±1993, 2354 patients underwent implantation of penile prostheses. The total number of penile prostheses implanted has declined over this six year period. Similarly, hospital stay has declined from an average of 4.03±2.96 d with a 46.6% decrease in total hospital days. Despite this change in hospital stay, hospital charges rose signi®cantly from an average of $7252.48 to $12 842.18 driving total charges from $2 973 516.80 to $3 826 969.60 (1993) representing a 28.7% increase. Conclusions: Minimally invasive therapy and changes in reimbursement have had a major impact on the number of patients undergoing penile prosthesis implantation for ED. This downward trend may continue as more treatment options develop from the marked increase in research in this ®eld. However, this may result in an increase of patients seeking treatment overall.
Introduction
Penile prosthesis implantation is a common surgical treatment for male erectile dysfunction (ED). The long-term results of penile prosthetic implants demonstrate patient and partner satisfaction rates between around 60±80%, and approximately 5% long-term mechanical failure rate in the modern penile prosthesis. 1 However, the Gallup Poll commissioned by the American Urological Association (AUA) shows that minimally invasive treatments such as intracavernous injection therapy, the vacuum erection device and systemic therapy have changed the frequency of penile prosthesis surgery. 2 Patients prefer the least invasive form of therapy, despite less satisfactory results with these less invasive methods. 3 The cost of penile prosthesis surgery is also a concern for insurance carriers. Recent estimates suggested that the number of American men aficted with ED is 10±20 million, and including partial erectile dysfunction the estimate increases to about 30 million. 4 In addition to research into less invasive treatment options, local and regional anesthesia and outpatient surgery for prosthetic placement are being investigated. 5, 6 The purpose of this study is to evaluate the trends of penile prosthesis implantation with attention to the changes in frequency of implants performed, hospital stay, hospital charges and penile prosthesis type in North Carolina.
Methods
The data source was a statewide hospital discharge database which includes all hospital discharges coded by ICD-9 and CPT codes. All 151 hospitals in North Carolina were included. US government and military hospitals were excluded. Patients were selected by procedure of penile prosthesis, and other penile surgery was excluded. The data was based on CPT and ICD-9 codes for non-in¯atable (54400 and 64.95, respectively) and in¯atable (54405 and 64.97, respectively) penile prosthesis implantation.
Results
A total of 2354 men underwent penile prosthesis implantation between 1988±1993. The mean patient age over this time was 57 y and did not change signi®cantly during the survey (Figure 1 ). Although the population of North Carolina has increased by approximately 6%, the number of penile prostheses implanted has declined during this six year period, most notably in the in¯atable multiple-piece prosthesis ( Figure 2) . Similarly, the length of hospital stay has declined from an average of 4. 
Discussion
The Clinical Guidelines Panel on erectile dysfunction convened by the AUA analyzed the literature regarding available methods for treating organic erectile dysfunction and made practice recommendations based on the treatment outcomes data. 7 They concluded that for the standard patient, de®ned as a man with acquired organic erectile dysfunction without evidence of a hormonal etiology, three treatment options should be offered: vacuum erection devices (VED), vasoactive drug injection therapy and penile prosthesis implantation. 
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The Panel felt that oral therapy with yohimbine was not effective for the standard patient. Similar results have been seen in mixed type impotence where yohimbine was no better than placebo as ®rst-line treatment. 8 With the development of new agents such as sildena®l, however, oral therapy may prove to be effective treatment for ED. 9 The VED has an overall success rate of approximately 90%, and 83.5% of patients continue to use the device for intercourse. 10 In addition, when comparing injection therapy with the vacuum device, the former has been shown to provide a better ability to attain erection with an increase in overall satisfaction of the patient and partner.
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These non-surgical treatment options, together with the marked increase in research and development of new pharmacotherapeutic options including alprostodil urethral suppositories, are responsible for the replacement of penile prosthetic surgery as the ®rst-line treatment of ED. 12 Our retrospective analysis of 2354 patients who underwent penile prosthesis implantation in the state of North Carolina during a six year period demonstrates a trend toward fewer prosthesis placements. This decline is inspite of clear evidence that surgical treatment of ED has the highest patient satisfaction rate. 3 We believe that this decline re¯ect the impact of minimally invasive therapy for ED. The changes in reimbursement may also have a signi®cant impact on the number of penile prostheses placed. Interestingly, despite a signi®cant decrease in hospital stay of approximately one day, and a decrease in the number of prostheses placed, the total annual hospital charges for penile prosthesis surgery increased by almost one million dollars from 1988±1993 in North Carolina.
The evolving changes in societal attitudes toward human sexuality and the signi®cant advances in the understanding of male erectile dysfunction during the last two decades have been accompanied by an increase in awareness and concern regarding erectile function. A study performed in Denmark on 439 51 y old men revealed that 40% reported some degree of sexual dysfunction; however, only 7% found their problems abnormal for their age and only 5% of the interviewed men intended to seek treatment. 13 As these advances continue, perhaps the urologist treating ED will see an increase in the number of men seeking treatment. As a result there may be an increase in penile prosthesis surgery for those refractory to minimally invasive therapy.
Conclusion
Minimally invasive therapy and changes in reimbursement have had a major impact on the number of patients undergoing penile prosthesis implantation for male erectile dysfunction. Over a six year period in North Carolina, increases in ef®ciency of care have decreased hospital stay signi®cantly. Hospital cost per penile prosthesis has risen substantially such that total expenditures for penile prostheses in North Carolina has increased signi®-cantly despite the decrease in numbers of patients treated. In the future, the increase in the number of men seeking therapy for erectile dysfunction due in part to the recent advances in pharmacotherapy may increase the frequency of penile prosthesis surgery for refractory cases.
